代谢性疾病中的亚临床心肌损害
本文综述2型糖尿病与肥胖对非缺血性心力衰竭和心房颤动的影响,指出2型糖尿病使心力衰竭风险增加2至5倍,体重指数每增加一个单位男性心力衰竭风险增加5%、女性增加7%,心房颤动风险增加约6%;代谢性心肌病在无症状期即可出现影像可识别的结构与功能改变,可用于监测疾病进展或治疗反应。
要点
- 2型糖尿病使心力衰竭风险增加2至5倍,肥胖使男性心力衰竭风险每单位体重指数增加5%、女性增加7%。
- 体重指数每增加一个单位,心房颤动风险增加约6%。
- 代谢性心肌病在无症状期即可出现影像可识别的结构与功能改变,可用于监测疾病进展或治疗反应。
核心结论
- 代谢性心肌病在无症状阶段即存在影像可识别的结构与功能改变,早期检出亚临床心肌异常可能有助于监测疾病进展或治疗反应。
研究设计与样本
- 综述,旨在让临床医生了解早期检出临床前心肌异常的可能获益及可能指导干预以预防2型糖尿病和肥胖患者疾病进展的机制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Type 2 diabetes mellitus (T2DM) and obesity are important contributors to nonischemic heart failure (HF) and atrial fibrillation. There is a 2- to 5-fold increase in HF associated with T2DM, and there is a 5% in HF risk in men and 7% increment in women for every unit increment in body mass index, after adjustment for traditional cardiovascular risk factors. Likewise, the risk of atrial fibrillation increases by about 6% per unit increase in body mass index. Metabolic cardiomyopathy leads to a number of changes in cardiac structure and function that can be recognized by imaging in the asymptomatic phase, and these parameters can be used for monitoring the progression of disease or the response to therapy. The purpose of this review is to familiarize clinicians with the potential benefits of early detection of preclinical myocardial abnormalities, as well as the mechanisms that might inform interventions to prevent disease progression in patients with T2DM and obesity.
引用
- Kosmala W, Sanders P, Marwick TH, et al. Subclinical Myocardial Impairment in Metabolic Diseases. JACC Cardiovasc Imaging. 2017. PMID: 28595844. doi:10.1016/j.jcmg.2017.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。